Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation

Documents similaires

• Patterns of recurrence after curative resection and adjuvant chemotherapy in gastric and gastroesophageal junction cancer
  par: Chengzhi Wei, et autres
  Publié: (2026)
• Risk of second primary malignancies after adjuvant chemotherapy for colon cancer
  par: Tomas Buchler, et autres
  Publié: (2025)
• Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer
  par: Sachiyo Onishi, et autres
  Publié: (2024)
• Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer
  par: Alberto Mendoza‐Valderrey, et autres
  Publié: (2024)
• Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
  par: Osamu Maeda, et autres
  Publié: (2024)